Health-related quality of life after IMRT or IMRT plus HDR brachytherapy for intermediate or high-risk prostate cancer: Five-year results of a prospective trial.

被引：0
|
作者：
Guix, Benjamin
Maria Lacorte, Teresa
Maria Bartrina, Jose
Ignacio Tello, Jose
Guix, Ines
Galdon, Guillermo
Espino, Marc
Guix, Teresa
机构：
[1] IMOR Fdn, Barcelona, Spain
[2] Imor Fdn, Med Inst Radiotherapy & Oncol, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16071
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Quality of Life After IMRT or IMRT plus HDR Brachytherapy for Intermediate- or High-Risk Prostate Cancer: 8-Year Results of a Prospective Trial
    Guix, B.
    Lacorte, T.
    Bartrina, J.
    Tello, J.
    Guix, I.
    Galdon, G.
    Espino, M.
    Guix, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S386 - S386
  • [2] CONCOMITANT HYPOFRACTIONATED IMRT BOOST FOR LOCALIZED HIGH-RISK PROSTATE CANCER: FIVE YEAR RESULTS OF A PROSPECTIVE TRIAL
    Cheung, Patrick
    Morton, Gerard
    Szumacher, Ewa
    Danjoux, Cyril
    Chung, Hans
    Vesprini, Danny
    Chu, William
    Choo, Richard
    Deabreu, Andrea
    Zhang, Liying
    Loblaw, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S38 - S38
  • [3] Combined HDR brachytherapy boost plus external beam radiotherapy by IMRT versus external beam radiotherapy alone IMRT in intermediate- and high-risk prostate cancer: Dosimetric analysis from a randomized control trial.
    Annamalai, Manikandan
    Ma, Laviraj
    Kunhiparambath, Haresh
    Sharma, Dayanand
    Gupta, Subhash
    Mallick, Supriya
    Julka, Pramod Kumar
    Rath, Goura Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [4] Comparison of High-Dose IMRT (86.4 Gy) to Combined Brachytherapy Plus IMRT for Intermediate-Risk Prostate Cancer
    Spratt, D. E.
    Kollmeier, M.
    Zumsteg, Z.
    Pirus, G.
    Yamada, Y.
    Cohen, G.
    Polkinghorn, W.
    Pei, X.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S127 - S127
  • [5] Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer
    Spratt, Daniel E.
    Zumsteg, Zachary S.
    Ghadjar, Pirus
    Kollmeier, Marisa A.
    Pei, Xin
    Cohen, Gilad
    Polkinghorn, William
    Yamada, Yoshiya
    Zelefsky, Michael J.
    BJU INTERNATIONAL, 2014, 114 (03) : 360 - 367
  • [6] Outcome and quality of life after HDR brachytherapy in patients with high-risk localized prostate cancer
    Zinkin, H
    Roth, R
    Lo, T
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S53 - S53
  • [7] Concomitant Hypofractionated IMRT Boost for High-Risk Prostate Cancer: 5 Year Results
    Cheung, P.
    Loblaw, D.
    Szumacher, E.
    Danjoux, C.
    Choo, R.
    Zhang, L.
    Mamedov, A.
    Deabreu, A.
    Morton, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S106 - S106
  • [8] High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation
    Hjalm-Eriksson, Marie
    Ullen, Anders
    Nilsson, Sten
    Johansson, Hemming
    Nilsson, Josef
    Castellanos, Enrique
    Brandberg, Yvonne
    ACTA ONCOLOGICA, 2022, 61 (10) : 1179 - 1185
  • [9] Five-Year Outcomes of HDR Brachytherapy and Radiation Therapy Combined With ADT for Intermediate Prostate Cancer: A Phase 2 Trial
    Jolicoeur, M.
    Tetreault, A.
    Nguyen-Huynh, T. V.
    Benoit, N.
    Guay, J. P.
    Fortin, B.
    Vincent, F.
    Lambert, C.
    Saad, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E249 - E250
  • [10] Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer
    Korfage, IJ
    Essink-Bot, ML
    Borsboom, GJJM
    Madalinska, JB
    Kirkels, WJ
    Habbema, JDF
    Schröder, FH
    de Koning, HJ
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (02) : 291 - 296
12345